PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Min-Hsi Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chest Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Glycolysis, Cell Differentiation, Myofibroblasts, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Kaohsiung Veterans General Hospital, VGH, TSGH, AS Joint Research Program.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer‐related deaths worldwide. Patients with lung cancer usually exhibit poor prognoses and low 5‐year survival rates. Idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) are both chronic lung dysfunctions resulting in lung fibrosis and increased risk of lung cancer. Myofibroblasts contribute to the progression of asthma, COPD and IPF, leading to fibrosis in the airway and lungs. A growing body of evidence demonstrates that metabolic reprogramming is a major hallmark of fibrosis, being important in the progression of fibrosis. Using gene expression microarray, we identified and validated that the lipid metabolic pathway was upregulated in lung fibroblasts upon interleukin (IL)‐4, IL‐13 and tumour necrosis factor (TNF)‐α treatment. In this study, we described that prostaglandin E synthase ( PTGES ) was upregulated in lung fibroblasts after IL‐4, IL‐13 and TNF‐α treatments. PTGES increased α‐SMA levels and promoted lung fibroblast cell migration and invasion abilities. Furthermore, PTGES was upregulated in a lung fibrosis rat model in vivo. PTGES increased AKT phosphorylation, leading to activation of the HIF‐1α‐glycolysis pathway in lung fibroblast cells. HIF‐1α inhibitor or 2‐DG treatments reduced α‐SMA expression in recombinant PTGES (rPTGES)‐treated lung fibroblast cells. Targeting PGE 2 signalling in PTGES‐overexpressing cells by a PTGES inhibitor reduced α‐SMA expression. In conclusion, the results of this study demonstrate that PTGES increases the expression of myofibroblast marker via HIF‐1α‐dependent glycolysis and contributes to myofibroblast differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chest Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Pathology and Laboratory Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
- Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Min-Hsi Lin, Yi-Chen Lee, Yi-Fang Yang
Förderung
- National Science and Technology Council, Taiwan
- Kaohsiung Veterans General Hospital
- VGH, TSGH, AS Joint Research Program
Zitieren
APA
Lin, M. H., Lee, Y. C., Liao, J. B., Chou, C. Y., & Yang, Y. F. (2024). PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70157
Vancouver
Lin MH, Lee YC, Liao JB, Chou CY, Yang YF. PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70157
BibTeX
@article{Lin2024,
author = {Lin, Min-Hsi and Lee, Yi-Chen and Liao, Jia-Bin and Chou, Chih-Yu and Yang, Yi-Fang},
title = {PTGES is involved in myofibroblast differentiation via HIF ‐1α‐dependent glycolysis pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70157}
}
EUVIMED